Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3

Alessandra Mangia, Franco Bandiera, Giuseppe Montalto, Leonardo Mottola, Valeria Piazzolla, Nicola Minerva, Adriano Pellicelli, Giovanni L. Ricci, Marina Cela, Vito Carretta, Gaetano Scotto, Donato Bacca, Brigida Annicchiarico, Mario Romano, Maurizio Russello, Giorgio Barbarini, Ernesto Agostinacchio, Angelo Andriulli

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background & Aims: The benefit of individualizing treatment for patients with genotype 3 HCV infection on the basis of viral clearance at week 4 (wk4-R) has not been firmly established. Methods: Four hundred and fourteen patients received Peg-interferon alpha-2b plus 1000-1200 mg of ribavirin daily according with body weight > or

Original languageEnglish
Pages (from-to)1000-1005
Number of pages6
JournalJournal of Hepatology
Volume53
Issue number6
DOIs
Publication statusPublished - Dec 2010

Fingerprint

interferon alfa-2b
Ribavirin
Genotype
Body Weight
Therapeutics
Infection

Keywords

  • HCV genotype 3
  • Peg-interferon
  • Ribavirin
  • Short treatment

ASJC Scopus subject areas

  • Hepatology

Cite this

Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3. / Mangia, Alessandra; Bandiera, Franco; Montalto, Giuseppe; Mottola, Leonardo; Piazzolla, Valeria; Minerva, Nicola; Pellicelli, Adriano; Ricci, Giovanni L.; Cela, Marina; Carretta, Vito; Scotto, Gaetano; Bacca, Donato; Annicchiarico, Brigida; Romano, Mario; Russello, Maurizio; Barbarini, Giorgio; Agostinacchio, Ernesto; Andriulli, Angelo.

In: Journal of Hepatology, Vol. 53, No. 6, 12.2010, p. 1000-1005.

Research output: Contribution to journalArticle

Mangia, A, Bandiera, F, Montalto, G, Mottola, L, Piazzolla, V, Minerva, N, Pellicelli, A, Ricci, GL, Cela, M, Carretta, V, Scotto, G, Bacca, D, Annicchiarico, B, Romano, M, Russello, M, Barbarini, G, Agostinacchio, E & Andriulli, A 2010, 'Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3', Journal of Hepatology, vol. 53, no. 6, pp. 1000-1005. https://doi.org/10.1016/j.jhep.2010.04.042
Mangia, Alessandra ; Bandiera, Franco ; Montalto, Giuseppe ; Mottola, Leonardo ; Piazzolla, Valeria ; Minerva, Nicola ; Pellicelli, Adriano ; Ricci, Giovanni L. ; Cela, Marina ; Carretta, Vito ; Scotto, Gaetano ; Bacca, Donato ; Annicchiarico, Brigida ; Romano, Mario ; Russello, Maurizio ; Barbarini, Giorgio ; Agostinacchio, Ernesto ; Andriulli, Angelo. / Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3. In: Journal of Hepatology. 2010 ; Vol. 53, No. 6. pp. 1000-1005.
@article{95733d4508e84c1ca70eaaffddf1c8d3,
title = "Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3",
abstract = "Background & Aims: The benefit of individualizing treatment for patients with genotype 3 HCV infection on the basis of viral clearance at week 4 (wk4-R) has not been firmly established. Methods: Four hundred and fourteen patients received Peg-interferon alpha-2b plus 1000-1200 mg of ribavirin daily according with body weight > or",
keywords = "HCV genotype 3, Peg-interferon, Ribavirin, Short treatment",
author = "Alessandra Mangia and Franco Bandiera and Giuseppe Montalto and Leonardo Mottola and Valeria Piazzolla and Nicola Minerva and Adriano Pellicelli and Ricci, {Giovanni L.} and Marina Cela and Vito Carretta and Gaetano Scotto and Donato Bacca and Brigida Annicchiarico and Mario Romano and Maurizio Russello and Giorgio Barbarini and Ernesto Agostinacchio and Angelo Andriulli",
year = "2010",
month = "12",
doi = "10.1016/j.jhep.2010.04.042",
language = "English",
volume = "53",
pages = "1000--1005",
journal = "Journal of Hepatology",
issn = "0168-8278",
publisher = "Elsevier B.V.",
number = "6",

}

TY - JOUR

T1 - Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3

AU - Mangia, Alessandra

AU - Bandiera, Franco

AU - Montalto, Giuseppe

AU - Mottola, Leonardo

AU - Piazzolla, Valeria

AU - Minerva, Nicola

AU - Pellicelli, Adriano

AU - Ricci, Giovanni L.

AU - Cela, Marina

AU - Carretta, Vito

AU - Scotto, Gaetano

AU - Bacca, Donato

AU - Annicchiarico, Brigida

AU - Romano, Mario

AU - Russello, Maurizio

AU - Barbarini, Giorgio

AU - Agostinacchio, Ernesto

AU - Andriulli, Angelo

PY - 2010/12

Y1 - 2010/12

N2 - Background & Aims: The benefit of individualizing treatment for patients with genotype 3 HCV infection on the basis of viral clearance at week 4 (wk4-R) has not been firmly established. Methods: Four hundred and fourteen patients received Peg-interferon alpha-2b plus 1000-1200 mg of ribavirin daily according with body weight > or

AB - Background & Aims: The benefit of individualizing treatment for patients with genotype 3 HCV infection on the basis of viral clearance at week 4 (wk4-R) has not been firmly established. Methods: Four hundred and fourteen patients received Peg-interferon alpha-2b plus 1000-1200 mg of ribavirin daily according with body weight > or

KW - HCV genotype 3

KW - Peg-interferon

KW - Ribavirin

KW - Short treatment

UR - http://www.scopus.com/inward/record.url?scp=78049452611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049452611&partnerID=8YFLogxK

U2 - 10.1016/j.jhep.2010.04.042

DO - 10.1016/j.jhep.2010.04.042

M3 - Article

VL - 53

SP - 1000

EP - 1005

JO - Journal of Hepatology

JF - Journal of Hepatology

SN - 0168-8278

IS - 6

ER -